España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
EOM Pharma Hldgs
IMUC
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.0182
-0.14
-88.63%
After Hours: Feb 23, 4:01 PM EDT
Get Report
Comment
EOM Pharma Hldgs (IMUC) Forecast
News
Earnings
EOM Pharma Hldgs (IMUC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for EOM Pharma Hldgs (OTC:IMUC) Stock
EOM Pharma Hldgs Stock (OTC: IMUC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, October 23, 2019
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Wednesday, October 17, 2018
ImmunoCellular Shares Resume Trade
Benzinga Newsdesk
ImmunoCellular Announces Receipt Of Notice Of...
Benzinga Newsdesk
Tuesday, October 16, 2018
ImmunoCellular Therapeutics Shares To Suspend...
Benzinga Newsdesk
ImmunoCellular Therapeutics Shares Halted, Ne...
Benzinga Newsdesk
The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist
Shanthi Rexaline
ImmunoCellular Therapeutics shares are tradin...
Benzinga Newsdesk
Monday, October 15, 2018
ImmunoCellular Therapeutics Announces Delisti...
Benzinga Newsdesk
Monday, August 13, 2018
ImmunoCellular Q2 EPS $(0.01) Up From $(1.14)...
Benzinga Newsdesk
Thursday, July 19, 2018
ImmunoCellular Therapeutics Announces Agreeme...
Benzinga
Monday, May 14, 2018
ImmunoCellular Q1 EPS $(0.02) Up From $(1.64) YoY
Benzinga
Thursday, April 12, 2018
Penny Stock ImmunoCellular Therapeutics Share...
Benzinga
ImmunoCellular Reports Successful Transfer Of...
Benzinga
Monday, March 26, 2018
ImmunoCellular Announces Receipt of a Going C...
Benzinga
Tuesday, March 13, 2018
ImmunoCellular Therapeutics Shares Up 5% Afte...
Benzinga
ImmunoCellular Therapeutics Reports Q4 EPS $(...
Benzinga
Thursday, February 22, 2018
ImmunoCellular Therapeutics Reports Will Revi...
Benzinga
Tuesday, February 13, 2018
Immunocellular Reports During Q4 Received ~...
Benzinga
Thursday, December 14, 2017
ImmunoCellular Therapeutics +162% Premarket @...
Benzinga
Wednesday, December 13, 2017
ImmunoCellular Therapeutics Achieves Stem-to-T-Cell Research Milestone, Successfully Packaging a T Cell Receptor DNA Sequence Into A A Lentiviral Vector
Benzinga
Tuesday, November 21, 2017
ImmunoCellular Therapeutics Reports Q3 EPS $(...
Benzinga
Wednesday, September 13, 2017
ImmunoCellular Therapeutics Announces NYSE Ha...
Benzinga
Wednesday, August 23, 2017
UPDATE: ImmunoCellular Says 'Near-Term Milest...
Benzinga
UPDATE: ImmunoCellular Highlights 'Restructur...
Benzinga
ImmunoCellular Therapeutics Offers Update On ...
Benzinga
Monday, August 14, 2017
ImmunoCellular Therapeutics Reports Q2 EPS $(...
Benzinga
Tuesday, July 18, 2017
ImmunoCellular Therapeutics Prices Convertible Preferred Stock and Warrants
Benzinga
Friday, July 07, 2017
15 Biggest Mid-Day Losers For Thursday
Benzinga
Wednesday, July 05, 2017
12 Biggest Mid-Day Gainers For Wednesday
Benzinga
ImmunoCellular Therapeutics Shares Resume Tra...
Benzinga
Thursday, June 29, 2017
ImmunoCellular Therapeutics Receives Delisting Notice From NYSE
Benzinga
Wednesday, June 21, 2017
Adam Feuerstein Tweets: The $IMUC lesson: Try...
Benzinga
ImmunoCellular Therapeutics Suspends ICT-107 ...
Benzinga
Monday, June 05, 2017
ImmunoCellular Says Survival Data from ICT-12...
Benzinga
Tuesday, May 16, 2017
18 Biggest Mid-Day Losers For Tuesday
Benzinga
Monday, May 15, 2017
ImmunoCellular Therapeutics Reports Q1 EPS $(...
Benzinga
Thursday, April 20, 2017
8-K from Immunocellular Therapeutics Shows Da...
Benzinga
Tuesday, April 04, 2017
Immunocellular Therapeutics Files to Sell Up ...
Benzinga
Friday, March 24, 2017
16 Stocks Moving In Friday's Pre-Market Session
Benzinga
Tuesday, March 14, 2017
ImmunoCellular Therapeutics Gets Audit Opinion With Going Concern Explanation
Benzinga
Thursday, March 09, 2017
ImmunoCellular Therapeutics Reports FY16 EPS...
Benzinga
Monday, March 06, 2017
ImmunoCellular Therapeutics Gives ICT-107 Phase 3 Trial Update
Benzinga
Tuesday, February 14, 2017
Immunocellular Therapeutics Spikes to High of...
Benzinga
Wednesday, January 11, 2017
15 Biggest Mid-Day Losers For Wednesday
Benzinga
Wednesday, December 28, 2016
10 Biggest Mid-Day Losers For Wednesday
Benzinga
ImmunoCellular Therapeutics Files For Offerin...
Benzinga
Wednesday, December 07, 2016
Immunocellular Spikes to High of $3.17 on Vol...
Benzinga
Monday, November 21, 2016
ImmunoCellular Therapeutics Reports Updated Immune Monitoring Data from ICT-107 Phase 2 Trial
Benzinga
Wednesday, November 16, 2016
ImmunoCellular Announces 1:40 Reverse Split
Benzinga
Friday, November 11, 2016
Maxim Group Downgrades ImmunoCellular Therapeutics, Ltd. Common Stock to Hold
Benzinga
Show More
